Vertex Pharmaceuticals
VRTX
#180
Rank
$114.00 B
Marketcap
$444.64
Share price
1.75%
Change (1 day)
-5.24%
Change (1 year)

Vertex Pharmaceuticals (VRTX) - Total assets

Total assets on the balance sheet as of September 2025 : $24.86 Billion USD

According to Vertex Pharmaceuticals's latest financial reports the company's total assets are $24.86 Billion USD. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Vertex Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31$22.53 B-0.87%
2023-12-31$22.73 B25.23%
2022-12-31$18.15 B35.13%
2021-12-31$13.43 B14.3%
2020-12-31$11.75 B41.27%
2019-12-31$8.31 B33.18%
2018-12-31$6.24 B76.14%
2017-12-31$3.54 B22.41%
2016-12-31$2.89 B15.94%
2015-12-31$2.49 B7.02%
2014-12-31$2.33 B0.67%
2013-12-31$2.31 B-15.96%
2012-12-31$2.75 B25.18%
2011-12-31$2.20 B27.75%
2010-12-31$1.72 B-11.76%
2009-12-31$1.95 B99.44%
2008-12-31$0.98 B63.01%
2007-12-31$0.60 B-34.73%
2006-12-31$0.92 B67.87%
2005-12-31$0.54 B0.65%
2004-12-31$0.54 B-24.7%
2003-12-31$0.72 B-11.19%
2002-12-31$0.81 B-11.83%
2001-12-31$0.92 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
$58.53 B 135.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
$133.89 B 438.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$129.54 B 421.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$96.88 B 289.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$192.81 B 675.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
$0.30 B-98.79%๐Ÿ‡บ๐Ÿ‡ธ USA